CGH 2466 dihydrochloride

Discontinued Product

CGH 2466 dihydrochloride (Cat. No. 2344) has been withdrawn from sale for commercial reasons.
Cat.No. 2344 - CGH 2466 dihydrochloride | C14H9N3SCl2.2HCl | CAS No. 1177618-54-0
Description: A1, A2B and A3 antagonist and inhibitor of p38 MAPK and PDE4
Chemical Name: 4-(3,4-Dichlorophenyl)-5-(4-pyridinyl)-2-thiazolamine dihydrochloride
Purity: ≥99% (HPLC)
Datasheet
Citations (1)
Reviews
Literature (4)

Biological Activity for CGH 2466 dihydrochloride

CGH 2466 dihydrochloride is an adenosine A1, A2B and A3 receptor antagonist (IC50 values are 19, 21, and 80 nM respectively). Also inhibits p38 MAPK (IC50 = 187 - 400 nM) and phosphodiesterase type 4D (IC50 = 22 nM). Displays potent anti-inflammatory effects in vitro and in vivo. Potentially useful for asthma and chronic obstructive pulmonary disease (COPD) research.

Technical Data for CGH 2466 dihydrochloride

M. Wt 395.13
Formula C14H9N3SCl2.2HCl
Storage Desiccate at +4°C
Purity ≥99% (HPLC)
CAS Number 1177618-54-0
PubChem ID 16759176
InChI Key WHXRCTIBFLXKFD-UHFFFAOYSA-N
Smiles Cl.Cl.NC1=NC(=C(S1)C1=CC=NC=C1)C1=CC(Cl)=C(Cl)C=C1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for CGH 2466 dihydrochloride

References for CGH 2466 dihydrochloride

References are publications that support the biological activity of the product.

Trifilieff et al (2005) CGH2466, a combined adenosine receptor antagonist, p38 mitogen-activated protein kinase and phosphodiesterase type 4 inhibitor with potent in vitro and in vivo anti-inflammatory activities. Br.J.Pharmacol. 144 1002 PMID: 15685201

View Related Products by Product Action

View all Non-selective Adenosine Antagonists

Keywords: CGH 2466 dihydrochloride, CGH 2466 dihydrochloride supplier, A1, A2B, A3, antagonists, inhibitors, inhibits, p38, MAPK, PDE4, Anti-inflammatory, agent, adenosines, receptor, Non-Selective, Receptors, Phosphodiesterases, CGH2466, dihydrochloride, Non-selective, Adenosine, 2344, Tocris Bioscience

1 Citation for CGH 2466 dihydrochloride

Citations are publications that use Tocris products. Selected citations for CGH 2466 dihydrochloride include:

Wakisaka et al (2017) An Adenosine Receptor for Olfaction in Fish. Curr Biol 27 1437 PMID: 28502661


Reviews for CGH 2466 dihydrochloride

There are currently no reviews for this product. Be the first to review CGH 2466 dihydrochloride and earn rewards!

Have you used CGH 2466 dihydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cardiovascular

Cardiovascular Research Product Guide

A collection of over 250 products for cardiovascular research, the guide includes research tools for the study of:

  • Hypertension
  • Thrombosis and Hemostasis
  • Atherosclerosis
  • Myocardial Infarction
  • Ischemia/Reperfusion Injury
  • Arrhythmias
  • Heart Failure
GPCR

GPCR Product Listing

A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

  • Rhodopsin-like Receptors
  • Glutamate Receptors
  • Frizzled Receptors
  • GPCR Signaling
Pain

Pain Research Product Guide

A collection of over 280 products for pain research, the guide includes research tools for the study of:

  • Nociception
  • Ion Channels
  • G-Protein-Coupled Receptors
  • Intracellular Signaling
Cardiovascular

Cardiovascular Poster

Cardiovascular disease remains one of the major causes of morbidity and mortality in the Western world and therefore this therapeutic area continues to be of great interest to researchers. This poster highlights the key GPCRs regulating vascular reactivity.